More than 50% of US adults are expected to have high-sensitivity C-reactive protein, a blood pressure condition caused by a protein in the body that raises the risk of heart attacks, strokes and cancer.
Some medical products, such as blood pressure medications and blood pressure devices, can lower the risk by preventing the buildup of abnormal proteins in the blood.
But new research shows there’s a more powerful way to treat C-respiratory problems: by using holographic devices that mimic the body’s own blood vessels.
Researchers at Emory University have developed a new, patented blood pressure device called a photoreceptor that can be placed on the outside of a patient’s body, with its own blood vessel.
The device is based on a technology that can change the way the blood vessels of the human body function.
It can change blood flow and reduce the pressure in the brain, helping the body to relax.
“There is a big demand for a new way to diagnose, treat and monitor C-related disorders and this is a new area that we are working on,” said Dr. Paul Devereaux, a professor of biomedical engineering at Emery and senior author of a paper published online by the journal Science Translational Medicine.
The researchers designed the device using three different types of proteins that can bind to receptors on the surface of the blood vessel, allowing it to pick up the blood pressure signals.
When activated, these proteins produce a chemical called COX-2.
When this chemical breaks down in the presence of oxygen, the blood flow drops, which helps the blood to relax in a patient.
“This is a key piece of the puzzle to make it work,” Devereux said.
C-resverase, a gene in the red blood cells that produces the enzyme that breaks down COX enzymes, is an enzyme that helps the body remove excess COX from the blood, and COX inhibitors can slow down this process.
The researchers also developed a way to make the photoreceptors with specific chemical interactions with the proteins in a specific location.
“It is a very elegant and elegant way to do this,” Deveaux said.
The device was shown to work in mice, and is expected to be tested in people soon.
Researchers have already begun work on developing more advanced versions that would allow the device to mimic the human blood vessels and use different chemical compounds to change the proteins.